gvtcx

NHS Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals - 1 May 2023

NHS England Published 10 Nov 2022 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£359,779,000
Statusactive
Category (CPV) 33600000
RegionEast Midlands, East of England, London, North East, North West, South East, South West, West Midlands, Yorkshire and the Humber
Deadline12 Dec 2022
Contract start1 May 2023
Contract end30 Apr 2025
Procedureopen
SME suitableYes
OCIDocds-b5fd17-e83d294f-967a-4817-9842-0e48a7343457

description

NHS Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals

Offer reference number: CM/PHR/22/5675

CM/PHR/22/5675/01 - NHS Framework Agreement for Branded Medicines - National Category Tender Lot 1. Period of framework: 1 May 2023 to 30 April 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines - National Tender Lot 2. Period of framework: 1 May 2023 to 30 April 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
2 Dec 2022 Tender (tender) · f4bbff4e-2ce7-40dd-b3cf-e254cc346379-595600

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.